ARC Institution works on your behalf with full transparency to bring innovative medical device technologies to commercialization in Japan. We are dedicated to employing the most efficient, speedy and economic processes possible. Our business model allows overseas start-ups to control every step of the clinical & regulatory processes, and own your import license (shonin) upon approval. This model can be executed at a fraction of the cost of setting up a full infrastructure at the outset but allow for that flexibility in the future. More importantly though, avoid choosing the wrong distribution strategy and/or losing providing too much control to a potential distributor too early in the process.